18 Novartis Investigative Sites in the US — East Hanover, New Jersey

18 Novartis Investigative Sites in the US is a clinical research site located in East Hanover, New Jersey, United States 07936-1080.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

18 Novartis Investigative Sites in the US has participated in 1 clinical trials.

Therapeutic areas: Metastatic Non-Small Cell Lung Cancer.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 18 Novartis Investigative Sites in the US?

18 Novartis Investigative Sites in the US has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 18 Novartis Investigative Sites in the US conducted?

18 Novartis Investigative Sites in the US has 1 clinical trials on record. Their work covers Metastatic Non-Small Cell Lung Cancer.

Is 18 Novartis Investigative Sites in the US accredited by Crixeo Health?

18 Novartis Investigative Sites in the US has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 18 Novartis Investigative Sites in the US?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.